Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VanEck Vectors Biotech ETF (BBH)

Delayed Data
As of Oct 27
 +0.57 / +0.54%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors  US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.


1 month-9.68% 3 years+8.40%
3 months-6.46% 5 years--
1 year-14.99% Since inception+25.68%
Data through 10/28/2016

Quote Details

Previous close$105.82
Open day’s range106.28 – 107.88
Net asset value (NAV)106.36 (10/27/2016)
Daily volume93,143
Average volume (3 months)71,151
Data as of 10/27/2016

Peer Comparisonvs. Health ETFs

Performance 5-yr return--+20.22%
Expense Gross exp ratio0.40%0.48%
Risk 5 year sharpe ratio--1.28
Net assets$598.9M$1.1B
Average market cap$33.1B$36.3B
Average P/E17.820.0
Dividend / Share--0.22%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
AMGN Amgen12.52%
GILD Gilead Sciences11.26%
AGN Allergan9.58%
CELG Celgene9.37%
BIIB Biogen6.64%
ILMN Illumina Inc4.85%
REGN Regeneron Pharmaceuticals4.55%
BMRN Biomarin Pharmaceutical Inc4.43%
ALXN Alexion Pharmaceuticals Inc4.41%
INCY Incyte Corp4.15%

Search for Jobs